Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosis

Bioconjugate Chemistry

Volumn 25, Issue 3, 2014, Pages 601-610

  Lee, Sangmin ^a   Kang, Sun Woong ^b   Ryu, Ju Hee ^a   Na, Jin Hee ^a   Lee, Dong Eun ^c   Han, Seung Jin ^a   Kang, Choong Mo ^d   Choe, Yearn Seong ^d   Lee, Kyo Chul ^e   Leary, James F ^f   Choi, Kuiwon ^a   Lee, Kyung Han ^d   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Institute of Toxicology   (South Korea)

^c Korea Atomic Energy Research Institute   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Korea Institute of Radiation and Medical Science   (South Korea)

^f PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; GLYCOLS; MAGNETIC RESONANCE IMAGING; PROBES; TUMORS;

CHITOSAN NANOPARTICLES; DUAL IMAGING; GLYCOL CHITOSAN; IMAGING PROBE; MATRIX; METALLOPROTEINASES; MULTIMODAL IMAGING; OPTICAL POSITRON EMISSION TOMOGRAPHIES; OPTICAL-; PROBE-BASED;

POSITRON EMISSION TOMOGRAPHY;

ACTIVATED MATRIX METALLOPROTEINASE CHITOSAN NANOPARTICLE TETRAXAN COPPER 64; AZIDE; CHITOSAN; COLLAGENASE 3; DIBENZYL CYCLOOCTYNE; GELATINASE A; GELATINASE B; GLYCOL; MATRIX METALLOPROTEINASE; NANOPARTICLE; TETRAXETAN; UNCLASSIFIED DRUG; COPPER; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CELL HOMING; CHEMICAL STRUCTURE; CLICK CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; CONTROLLED STUDY; FLUORESCENCE IMAGING; ISOTOPE LABELING; MALE; MOLECULAR PROBE; MOUSE; MULTIMODAL IMAGING; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; ENZYMOLOGY; HUMAN; MCF 7 CELL LINE; METABOLISM; NANOTECHNOLOGY; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; OPTICAL INSTRUMENTATION; SYNTHESIS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; COPPER RADIOISOTOPES; GLYCOLS; HUMANS; MALE; MATRIX METALLOPROTEINASES; MCF-7 CELLS; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS, EXPERIMENTAL; OPTICAL DEVICES; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84896524686     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500020g     Document Type: Article

References (46)

1. Nikiforov, Y. E. and Nikiforova, M. N. (2011) Molecular genetics and diagnosis of thyroid cancer Nat. Rev. Endocrinol. 7, 569-80
2. Momparler, R. L. (2003) Cancer epigenetics Oncogene 22, 6479-83
3. Mariani-Costantini, R. (2013) Diagnosis: Breast cancer screening in rural African communities Nat. Rev. Clin. Oncol. 10, 185-6
4. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., Li, Q., Li, X., Wang, W., Zhang, Y., Wang, J., Jiang, X., Xiang, Y., Xu, C., Zheng, P., Zhang, J., Li, R., Zhang, H., Shang, X., Gong, T., Ning, G., Wang, J., Zen, K., Zhang, J., and Zhang, C. Y. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res. 18, 997-1006
5. Nam, T., Park, S., Lee, S. Y., Park, K., Choi, K., Song, I. C., Han, M. H., Leary, J. J., Yuk, S. A., Kwon, I. C., Kim, K., and Jeong, S. Y. (2010) Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging Bioconjugate Chem. 21, 578-82
6. Sun, I. C., Eun, D. K., Koo, H., Ko, C. Y., Kim, H. S., Yi, D. K., Choi, K., Kwon, I. C., Kim, K., and Ahn, C. H. (2011) Tumor-targeting gold particles for dual computed tomography/optical cancer imaging Angew. Chem. 50, 9348-51
7. Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., and Gambhir, S. S. (2008) Molecular imaging in drug development Nat. Rev. Drug Discovery 7, 591-607
8. Lee, D. E., Koo, H., Sun, I. C., Ryu, J. H., Kim, K., and Kwon, I. C. (2012) Multifunctional nanoparticles for multimodal imaging and theragnosis Chem. Soc. Rev. 41, 2656-72
9. Kryza, D., Taleb, J., Janier, M., Marmuse, L., Miladi, I., Bonazza, P., Louis, C., Perriat, P., Roux, S., Tillement, O., and Billotey, C. (2011) Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent Bioconjugate Chem. 22, 1145-52
10. Roberts, P. J., Stinchcombe, T. E., Der, C. J., and Socinski, M. A. (2010) Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? J. Clin. Oncol. 28, 4769-77
11. Ferrari, M. (2005) Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5, 161-71
12. Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., and Yasui, Y. (2001) Phases of biomarker development for early detection of cancer J. Natl. Cancer Inst. 93, 1054-61
13. Weissleder, R. (2006) Molecular imaging in cancer Science 312, 1168-71
14. Quon, A. and Gambhir, S. S. (2005) FDG-PET and beyond: molecular breast cancer imaging J. Clin. Oncol. 23, 1664-73
15. Gambhir, S. S. (2002) Molecular imaging of cancer with positron emission tomography Nat. Rev. Cancer 2, 683-93
16. Liu, S. (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides Adv. Drug Delivery Rev. 60, 1347-70
17. Hong, H., Zhang, Y., Sun, J., and Cai, W. (2009) Molecular imaging and therapy of cancer with radiolabeled nanoparticles Nano Today 4, 399-413
18. Liu, Y. and Welch, M. J. (2012) Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications Bioconjugate Chem. 23, 671-82
19. Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., and Tsourkas, A. (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities Science 338, 903-10
20. Koo, H., Huh, M. S., Ryu, J. H., Lee, D.-E., Sun, I.-C., Choi, K., Kim, K., and Kwon, I. C. (2011) Nanoprobes for biomedical imaging in living systems Nano Today 6, 204-220
21. Liu, T. W., Macdonald, T. D., Jin, C. S., Gold, J. M., Bristow, R. G., Wilson, B. C., and Zheng, G. (2013) Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases ACS Nano 7, 4221-32
22. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 65, 271-84
23. Shi, M., Lu, J., and Shoichet, M. S. (2009) Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer J. Mater. Chem. 19, 5485-5498
24. Lee, S., Choi, K. Y., Chung, H., Ryu, J. H., Lee, A., Koo, H., Youn, I. C., Park, J. H., Kim, I. S., Kim, S. Y., Chen, X., Jeong, S. Y., Kwon, I. C., Kim, K., and Choi, K. (2011) Real time, high resolution video imaging of apoptosis in single cells with a polymeric nanoprobe Bioconjugate Chem. 22, 125-31
25. Ryu, J. H., Kim, S. A., Koo, H., Yhee, J. Y., Lee, A., Na, J. H., Youn, I., Choi, K., Kwon, I. C., Kim, B.-S., and Kim, K. (2011) Cathepsin B-sensitive nanoprobe for in vivo tumor diagnosis J. Mater. Chem. 21, 17631-17634
26. Lee, S., Ryu, J. H., Park, K., Lee, A., Lee, S. Y., Youn, I. C., Ahn, C. H., Yoon, S. M., Myung, S. J., Moon, D. H., Chen, X., Choi, K., Kwon, I. C., and Kim, K. (2009) Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo Nano Lett. 9, 4412-6
27. Ryu, J. H., Na, J. H., Ko, H. K., You, D. G., Park, S., Jun, E., Yeom, H. J., Seo, D. H., Park, J. H., Jeong, S. Y., Kim, I. S., Kim, B. S., Kwon, I. C., Choi, K., and Kim, K. (2014) Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models Biomaterials 35, 2302-11
28. Lee, D. E., Na, J. H., Lee, S., Kang, C. M., Kim, H. N., Han, S. J., Kim, H., Choe, Y. S., Jung, K. H., Lee, K. C., Choi, K., Kwon, I. C., Jeong, S. Y., Lee, K. H., and Kim, K. (2013) Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging Mol. Pharmaceutics 10, 2190-8
29. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2, 161-74
30. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer Nature 420, 860-7
31. Na, J. H., Lee, S. Y., Lee, S., Koo, H., Min, K. H., Jeong, S. Y., Yuk, S. H., Kim, K., and Kwon, I. C. (2012) Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency J. Controlled Release 163, 2-9
32. Kwon, S., Park, J. H., Chung, H., Kwon, I. C., Jeong, S. Y., and Kim, I.-S. (2003) Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5 B -cholanic acid Langmuir 19, 10188-10193
33. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7, 743-8
34. Na, J. H., Koo, H., Lee, S., Min, K. H., Park, K., Yoo, H., Lee, S. H., Park, J. H., Kwon, I. C., Jeong, S. Y., and Kim, K. (2011) Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models Biomaterials 32, 5252-61
35. Lee, I., Yoon, K. Y., Kang, C. M., Lin, X., Chen, X., Kim, J. Y., Kim, S. M., Ryu, E. K., and Choe, Y. S. (2012) Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET Nucl. Med. Biol. 39, 840-6
36. Nahrendorf, M., Keliher, E., Marinelli, B., Waterman, P., Feruglio, P. F., Fexon, L., Pivovarov, M., Swirski, F. K., Pittet, M. J., Vinegoni, C., and Weissleder, R. (2010) Hybrid PET-optical imaging using targeted probes Proc. Natl. Acad. Sci. U.S.A. 107, 7910-5
37. Kelkar, S. S. and Reineke, T. M. (2011) Theranostics: combining imaging and therapy Bioconjugate Chem. 22, 1879-903
38. Josephson, L., Kircher, M. F., Mahmood, U., Tang, Y., and Weissleder, R. (2002) Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes Bioconjugate Chem. 13, 554-60
39. Janib, S. M., Moses, A. S., and MacKay, J. A. (2010) Imaging and drug delivery using theranostic nanoparticles Adv. Drug Delivery Rev. 62, 1052-63
40. Boyce, M. and Bertozzi, C. R. (2011) Bringing chemistry to life Nat. Methods 8, 638-42
41. Koo, H., Lee, S., Na, J. H., Kim, S. H., Hahn, S. K., Choi, K., Kwon, I. C., Jeong, S. Y., and Kim, K. (2012) Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles Angew. Chem. 51, 11836-40
42. Jewett, J. C. and Bertozzi, C. R. (2010) Cu-free click cycloaddition reactions in chemical biology Chem. Soc. Rev. 39, 1272-9
43. Zucker, S. and Vacirca, J. (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer Metastasis Reviews 23, 101-17
44. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295, 2387-92
45. Gupta, G. P. and Massague, J. (2006) Cancer metastasis: building a framework Cell 127, 679-95
46. Vihinen, P., Ala-aho, R., and Kahari, V. M. (2005) Matrix metalloproteinases as therapeutic targets in cancer Curr. Cancer Drug Targets 5, 203-20